TechNation Radio Podcast

On this week’s Tech Nation, Moira speaks with Journalist Alex Kantrowitz about his 2020 book, “Always Day One: How the Tech Titans Plan to Stay on Top Forever” which has spawned his work, as Founder and Editor of Big Technology. Then, Dr. Mark Sumeray, Chief Medical Officer of Amolyt Pharma, talks about their innovative approach to treating hormonal conditions.

On this week’s Tech Nation, Moira speaks with Science journalist and author, Annalee Newitz, joins me to talk about her book, “Stories are Weapons … Psychological Warfare and the American Mind”. Then, Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about the latest in Wearables, what they are doing now that they weren’t doing before.

On this week’s Tech Nation, Moira speaks with Dr. Sam Blackman, Founder and Head of Research and Development from Day One Biopharmaceuticals talks about their innovative approach to starting a biopharma company and how it led to a newly FDA approved drug that treats the most common form of brain cancer in children. Then, Dr. Daniel Kraft, Tech Nation Health, Chief Correspondent, talks about the rise of Robotic and Digitally-Enabled surgeries. And, Futurist and regular Tech Nation contributor, Dr. Alex Pang,  gives us a quick word on how to better manage the stress of life these days.

On this week’s Tech Nation, Moira speaks with Mustafa Suleyman, CEO of Inflection AI, about “The Coming Wave … Technology, Power, and the 21st Century’s Greatest Dilemma”. Then, Bloomberg columnist Adam Minter talks about his 2019 book, “Secondhand: Travels in the New Global Garage Sale.” You dropped it off at the thrift store … where does it go from there?

On this week’s Tech Nation, Moira speaks with Sports ecology professor and author Dr. Madeleine Orr, about her book, “Warming Up… How Climate Change is Changing Sport”. Then, Tech Nation Health Chief Correspondent Dr. Daniel Kraft talks about the Medical Innovation Gap, which is the time from innovation until we actually can use it in everyday practice. And Dr. John Scarlett, the President and CEO of Geron, tells us about their breakthrough drug candidate, which offers hope for treating bone marrow failure, previously only manageable through regular blood transfusions.

On this week’s Tech Nation, Moira speaks with Pulitzer-Prize winning author, Ed Humes, talks about his book, “Total Garbage… How We Can Fix Our Waste and Heal Our World.” Then, Dr. Steve Quake, Head of Science at the Chan Zuckerberg Initiative tells us about their ambitious goal to address all human diseases within the next century.

On this week’s Tech Nation, Moira speaks with Dr. Neil Kassell, the founder and chair of the Focused Ultrasound Foundation, about what focused ultrasound is and the different ways in which it is being used. Then, Dr. Nicholas Dirks, the President and CEO of the New York Academy of Sciences, talks about such topics as the International Science Reserve and how we might take on a new perspective regarding Artificial Intelligence.

On this week’s Tech Nation, Moira speaks with Dr. Neil Kassell, the founder and chair of the Focused Ultrasound Foundation, about what focused ultrasound is and the different ways in which it is being used. Then, Dr. Nicholas Dirks, the President and CEO of the New York Academy of Sciences, talks about such topics as the International Science Reserve and how we might take on a new perspective regarding Artificial Intelligence.

On this week’s Tech Nation, Moira speaks with Environmental journalist Clayton Page Aldern about his book, “The Weight of Nature … How a Changing Climate Changes Our Brains”. Then, Dr. Sean Bohen, President & CEO of Olema Oncology, talks about what we’ve learned about the 70% of breast cancers, called ER+/HER2- and how it relates to prostate cancer.

On this week’s Tech Nation, Moira speaks with journalist Jason Del Rey about Amazon and Walmart - how they are different and their designs on your attention. His book is “Winner Sells All: Amazon, Walmart, and the Battle for Our Wallets”.

Then, in biotech, breakthrough science changes the name of the game on how to make a medicine. Dr. Sanjay Shukla, the President and CEO of ATyr Pharma, takes this unprecedented approach and ATyr’s first drug candidate, which treats pulmonary sarcoidosis.